Methods of treating cancer using PPAR-gamma antagonists

Details for Australian Patent Application No. 2006223000 (hide)

Owner Center for Molecular Medicine and Immunology Immunomedics, Inc.

Inventors Blumenthal, Rosalyn; Burton, Jack

Agent Davies Collison Cave

Pub. Number AU-B-2006223000

PCT Pub. Number WO2006/099479

Priority 60/661,024 14.03.05 US

Filing date 14 March 2006

Wipo publication date 21 September 2006

Acceptance publication date 17 November 2011

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

Event Publications

4 October 2007 PCT application entered the National Phase

  PCT publication WO2006/099479 Priority application(s): WO2006/099479

30 June 2011 Application Accepted

  Published as AU-B-2006223000

28 July 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 07 Jul 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

17 November 2011 Application Accepted

  Published as AU-B-2006223000

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006223002-Macromolecules comprising a thioether cross-link

2006222990-Prophylaxis angles and cups